SCHEMBL20747622

SCHEMBL20747622

CCCCCCC(C)(CCCC)COC(=O)OCC(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LMNA P02545 5/20 0.37
HSD17B10 Q99714 1/20 0.37
SMPD1 P17405 3/20 0.35
TSHR P16473 2/20 0.35
CYP3A4 P08684 1/20 0.35
NFKB1 P19838 1/20 0.35
ADRA1A P35348 1/20 0.35
RAB9A P51151 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CES2 O00748 1/20 0.33
HTT P42858 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PLA2G2C Q5R387 1/20 0.33
KDM4E B2RXH2 1/20 0.33
DUSP3 P51452 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20747683 0.97 MAPT (0.39) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747576 0.94 LMNA (0.44) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747647 0.91 MAPT (0.37) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747725 0.86 MAPT (0.38) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL6896497 0.83 TSHR (0.34) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20747626 0.78 MAPT (0.36) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL21246104 0.78 LMNA (0.41) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL20853910 0.77 MEN1 (0.46) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL6896666 0.76 MAPT (0.37) MAPTMEN1KMT2AATML3MBTL1
SCHEMBL6895400 0.76 LMNA (0.38) MEN1KMT2ALMNAHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208045-B2 Aza-pyridone compounds and uses thereof ALIOS BIOPHARMA, INC. (US) 2019-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208045-B2 Aza-pyridone compounds and uses thereof PNPO, ITPA, PDXK MAPT 3216/4885MEN1 2269/4885KMT2A 1761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.